Loading...
Medreich Limited — Salicylic Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #5 for Salicylic · $1.0M export value · DGFT Verified
Medreich Limited is the #5 Indian exporter of Salicylic with $1.0M in export value and 77 verified shipments. Medreich Limited holds a 6.0% market share in Salicylic exports across 9 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| NETHERLANDS | $349.7K | 35 | 35.6% |
| UNITED ARAB EMIRATES | $303.5K | 25 | 30.9% |
| BANGLADESH | $212.2K | 8 | 21.6% |
| JORDAN | $50.0K | 1 | 5.1% |
| DENMARK | $25.5K | 4 | 2.6% |
| ETHIOPIA | $18.6K | 1 | 1.9% |
| ZIMBABWE | $11.3K | 1 | 1.2% |
| CAMBODIA | $9.0K | 1 | 0.9% |
| AFGHANISTAN | $2.7K | 1 | 0.3% |
Medreich Limited exports Salicylic to 9 countries. The largest destination is NETHERLANDS accounting for 35.6% of Medreich Limited's Salicylic shipments, followed by UNITED ARAB EMIRATES (30.9%) and BANGLADESH (21.6%). These destinations reflect Medreich Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| IMRES B V | NETHERLANDS | $349.7K | 35 |
| IMPERIAL MEDRICAL SOLUTIONS FZE | UNITED ARAB EMIRATES | $231.0K | 20 |
| WORLD HEALTH ORGANIZATION DHAKA | BANGLADESH | $212.2K | 8 |
| WORLD HEALTH ORGANIZTION JORDAN | JORDAN | $50.0K | 1 |
| IMPERIAL MEDICAL SOLUTIONS FZE | UNITED ARAB EMIRATES | $49.2K | 2 |
| UNICEF SUPPLY DIVISION |
India exported $12.5M worth of Salicylic through 2,799 shipments from 276 suppliers to 132 countries, serving 632 buyers globally. Medreich Limited contributes $1.0M to this total, accounting for 6.0% of India's Salicylic exports. Medreich Limited ships Salicylic to 9 countries through 11 buyers.
Medreich Limited's average Salicylic shipment value is $13.2K per consignment, based on 77 shipments totaling $1.0M. The largest destination is NETHERLANDS (35.6% of Medreich Limited's Salicylic exports).
Medreich Limited ranks #5 among 276 Indian Salicylic exporters with a 6.0% market share. The top 3 exporters are RECKITT BENCKISER (INDIA) PRIVATE LIMITED ($3.6M), RECKITT BENCKISER INDIA PRIVATE LIMITED ($2.2M), CIPLA LIMITED ($2.0M). Medreich Limited processed 77 shipments to 9 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ACETYL SALICYLIC ACID 75MG TABLETS 1X2 | $183.1K | 10 |
| ACETYL SALICYLIC ACID 75MG TABLETS 1X28 | $169.7K | 11 |
| ACETYL SALICYLIC ACID 75 MG TABLETS 1X28 | $58.8K | 3 |
| ACETYL SALICYLIC ACID 75MG TABLETS 1X28S(388393 PACKS) | $50.0K | 1 |
| ACETYL SALICYLIC ACID 75 MG TABLETS 1X2 | $46.3K | 2 |
| ACETYL SALICYLIC ACID 75MG TABLETS 1X28S (208412 PACKS) | $44.5K | 3 |
| ACETYL SALICYLIC ACID 75MG TABLETS 1X28S (156461 PACKS) | $33.6K | 1 |
| ACETYL SALICYLIC ACID 75MG TABLETS 1X28S (156156 PACKS) | $33.0K | 1 |
| ACETYL SALICYLIC ACID 75MG TABLETS 1X28S (156533 PACKS) |
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | RECKITT BENCKISER INDIA PRIVATE LIMITED | $2.2M | 86 | 1 | $25.6K |
| 3 | CIPLA LIMITED | $2.0M | 121 | 3 | $16.3K |
| 5 | MEDREICH LIMITED ★ | $1.0M | 77 | 9 | $13.2K |
| 6 | AUROBINDO PHARMA LTD | $745.3K | 40 | 2 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 412 | 14.7% |
| BANGALORE ICD | 324 | 11.6% |
| DELHI AIR CARGO ACC (INDEL4) | 319 | 11.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 268 | 9.6% |
| DELHI AIR | 201 | 7.2% |
| NHAVA SHEVA SEA (INNSA1) | 134 | 4.8% |
| JNPT/ NHAVA SHEVA SEA | 111 | 4.0% |
| JNPT | 109 | 3.9% |
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)
Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)
The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)
For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.
Medreich Limited exports 42 products worth $224.8M. Beyond Salicylic, top products include Amoxicillin, Potassium, Flucloxacillin, Rosuvastatin, Atorvastatin. View the complete Medreich Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Salicylic — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medreich Limited's Salicylic exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medreich Limited
Full Company Profile →
42 products · $224.8M total trade · 15 categories
| DENMARK |
| $25.5K |
| 4 |
| AL RAAYA DRUG STORE-UAE-AL AIN | UNITED ARAB EMIRATES | $23.2K | 3 |
| MINISTRY OF HEALTH | ETHIOPIA | $18.6K | 1 |
| MINISTRY OF HEALTH AND CHILD WELFAR | ZIMBABWE | $11.3K | 1 |
| MOPOTSYO-PATIENT INFORMATION CENTRE | CAMBODIA | $9.0K | 1 |
Medreich Limited supplies Salicylic to 11 buyers globally. The largest buyer is IMRES B V (NETHERLANDS), followed by IMPERIAL MEDRICAL SOLUTIONS FZE (UNITED ARAB EMIRATES) and WORLD HEALTH ORGANIZATION DHAKA (BANGLADESH). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| $33.0K |
| 1 |
| ACETYL SALICYLIC ACID 75 MG TABLETS 1X28S 154920 PACKS | $29.6K | 1 |
Medreich Limited exports 38 distinct Salicylic formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ACETYL SALICYLIC ACID 75MG TABLETS 1X2 with 10 shipments worth $183.1K.
| $18.6K |
| 7 | ACME GENERICS PRIVATE LIMITED | $686.1K | 19 | 1 | $36.1K |
Medreich Limited ranks #5 among 276 Indian Salicylic exporters. Average shipment value of $13.2K compared to the market average of $45.4K. The closest competitors by value are RECKITT BENCKISER INDIA PRIVATE LIMITED and CIPLA LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 132+ countries, 632+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Medreich Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Salicylic. For current shipment-level data, contact TransData Nexus.